Plasma Concentrations of Matrilysins (MMP-7, MMP-26) and Stromelysins (MMP-3, MMP-10) as Diagnostic Biomarkers in High-Grade Serous Ovarian Cancer Patients
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26125661 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Gacuta Ewa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Perinatology, University Clinical Hospital of Bialystok, 15-276 Bialystok, Poland. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Matrix Metalloproteinase 7, Biomarkers, Tumor, Matrix Metalloproteinase 10. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Ovarian cancer (OC) has an extremely unfavourable prognosis. This is due to its asymptomatic course and lack of screening tests. Therefore, new methods are needed to diagnose OC. The aim of this study was to evaluate the concentrations and diagnostic utility of selected matrilysins and stromelysins in the diagnosis of OC in comparison with the classical markers CA125 and HE4. The study group included 100 patients with serous OC, 70 with serous cysts (BL), and 50 healthy women (HW). Selected MMPs were determined by ELISA, routine markers by CMIA. Ovarian cancer patients have elevated concentrations of MMP-7, MMP-26, MMP-10 as well as CA125 and HE4 in the total group and subgroups (stage I + II, and III + IV). The highest values of diagnostic parameters—SP, SE, NPV, PPV, and ACC, as compared to CA125 and HE4, were observed for MMP-7. Performing ROC analyses showed that the highest AUC values were observed for MMP-7, CA125, and HE4, in the whole group of patients and divided into stages I and II according to FIGO. Performing ROC analyses for groups III and IV according to FIGO was associated with an increase in AUC for the MMPs studied. Of the MMPs tested, MMP-7, MMP-26, and MMP-10 have the highest potential in diagnostics of serous ovarian cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Perinatology, University Clinical Hospital of Bialystok, 15-276 Bialystok, Poland.
- Department of Population Medicine and Lifestyle Diseases Prevention, The Faculty of Medicine, Medical University of Białystok, 15-269 Bialystok, Poland.
- Department of Psychiatry, The Faculty of Medicine, Medical University of Białystok, 15-272 Bialystok, Poland.
- Department of Oncological Surgery, Bialystok Oncology Center, 15-027 Bialystok, Poland.
ORCID-Profile: Paweł Ławicki, Hanna Grabowska, Monika Kulesza
Zitieren
APA
Ewa, G., Ławicki, P., Grabowska, H., Ławicki, M., Kulesza, M., Kicman, A., Malinowski, P., & Ławicki, S. (2025). Plasma Concentrations of Matrilysins (MMP-7, MMP-26) and Stromelysins (MMP-3, MMP-10) as Diagnostic Biomarkers in High-Grade Serous Ovarian Cancer Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125661
Vancouver
Ewa G, Ławicki P, Grabowska H, Ławicki M, Kulesza M, Kicman A, et al. Plasma Concentrations of Matrilysins (MMP-7, MMP-26) and Stromelysins (MMP-3, MMP-10) as Diagnostic Biomarkers in High-Grade Serous Ovarian Cancer Patients. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125661
BibTeX
@article{Ewa2025,
author = {Ewa, Gacuta and Ławicki, Paweł and Grabowska, Hanna and Ławicki, Michał and Kulesza, Monika and Kicman, Aleksandra and Malinowski, Paweł and Ławicki, Sławomir},
title = {Plasma Concentrations of Matrilysins (MMP-7, MMP-26) and Stromelysins (MMP-3, MMP-10) as Diagnostic Biomarkers in High-Grade Serous Ovarian Cancer Patients},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26125661}
}
EUVIMED